Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Postpartum osteoporosis and vertebral fractures in two patients treated with enoxaparin during pregnancy

Abstract

Postpartum osteoporosis (PPO) is a rare disease associated with pregnancy and lactation period. Here, we report severe PPO and multiple vertebral compression fractures in two patients treated with enoxaparin—low-molecular-weight heparin (LMWH)—throughout their pregnancy. A 34-year-old woman who has delivered her second baby 3 months ago presented with severe low-back pain. She was treated with enoxaparin 40 mg/day for 8 months during her pregnancy. Dual-energy X-ray absorptiometry (DEXA) showed low T- and Z-scores in lumbar (L) vertebras. In magnetic resonance imaging (MRI), severe height losses in thoracic (T) 12, L1, and L2 vertebras were detected. She was diagnosed to have severe PPO and multiple vertebral compression fractures and was prescribed risedronate 35 mg/week, calcium, and vitamin D. The other patient was a 36-year-old woman diagnosed with PPO and vertebral fractures at the third week postpartum. She was also treated with enoxaparin 60 mg/day during her pregnancy. Severe osteoporosis in L vertebras and height losses indicative for compression fractures in T5–8, T11–12, and L2–5 vertebras were detected by DEXA and MRI, respectively. She was treated with calcitonin 200 U/day, calcium, and vitamin D. These findings suggest that vertebral compression fractures and PPO may be one of the causes of severe back pain in postpartum patients. Treatment with LMWH during pregnancy might be considered as a new risk factor for this rare condition.

This is a preview of subscription content, log in to check access.

Fig. 1

References

  1. 1.

    Kovacs CS (2011) Calcium and bone metabolism disorders during pregnancy and lactation. Endocrinol Metab Clin N Am 40(4):795–826

  2. 2.

    Di Gregorio S, Danilowicz K, Rubin Z, Mautalen C (2000) Osteoporosis with vertebral fractures associated with pregnancy and lactation. Nutrition 16(11–12):1052–1055

  3. 3.

    Sekhar RV, Vassilopoulou-Sellin R (2001) Interplay of pregnancy, lactation, and hyperthyroidism leading to severe osteoporosis in a young woman. Endocr Pract 7(4):262–266

  4. 4.

    Smith R, Athanasou NA, Ostlere SJ, Vipond SE (1995) Pregnancy-associated osteoporosis. QJM 88(12):865–878

  5. 5.

    Dunne F, Walters B, Marshall T, Heath DA (1993) Pregnancy associated osteoporosis. Clin Endocrinol (Oxf) 39(4):487–490

  6. 6.

    Rajgopal R, Bear M, Butcher MK, Shaughnessy SG (2008) The effects of heparin and low molecular weight heparins on bone. Thromb Res 122(3):293–298

  7. 7.

    Handschin AE, Trentz OA, Hoerstrup SP, Kock HJ, Wanner GA et al (2005) Effect of low molecular weight heparin (dalteparin) and fondaparinux (Arixtra) on human osteoblasts in vitro. Br J Surg 92(2):177–183

  8. 8.

    Folwarczna J, Janiec W, Sliwiński L (2004) Effects of heparin and low-molecular-weight heparins on bone mechanical properties in rats. Thromb Haemost 92(5):940–946

  9. 9.

    Kent GN, Price RI, Gutteridge DH, Allen JR, Rosman KJ et al (1993) Effect of pregnancy and lactation on maternal bone mass and calcium metabolism. Osteoporos Int Suppl 1:44–47

  10. 10.

    Ulrich U, Miller PB, Eyre DR, Chesnut CH 3rd, Schlebusch H et al (2003) Bone remodeling and bone mineral density during pregnancy. Arch Gynecol Obstet 268(4):309–316

  11. 11.

    Cross NA, Hillman LS, Allen SH, Krause GF, Vieira NE (1995) Calcium homeostasis and bone metabolism during pregnancy, lactation, and postweaning: a longitudinal study. Am J Clin Nutr 61(3):514–523

  12. 12.

    Ritchie LD, Fung EB, Halloran BP, Turnlund JR, Van Loan MD et al (1998) A longitudinal study of calcium homeostasis during human pregnancy and lactation and after resumption of menses. Am J Clin Nutr 67(4):693–701

  13. 13.

    Tran HA, Petrovsky N (2002) Pregnancy-associated osteoporosis with hypercalcaemia. Int Med J 32(9–10):481–485

  14. 14.

    O’Sullivan SM, Grey AB, Singh R, Reid IR (2006) Bisphosphonates in pregnancy and lactation-associated osteoporosis. Osteoporos Int 17(7):1008–1012

  15. 15.

    Phillips AJ, Ostlere SJ, Smith R (2000) Pregnancy-associated osteoporosis: does the skeleton recover? Osteoporos Int 11(5):449–454

  16. 16.

    Nelson-Piercy C (1997) Heparin-induced osteoporosis in pregnancy. Lupus 6(6):500–504

  17. 17.

    Pettilä V, Leinonen P, Markkola A, Hiilesmaa V, Kaaja R (2002) Postpartum bone mineral density in women treated for thromboprophylaxis with unfractionated heparin or LMW heparin. Thromb Haemost 87(2):182–186

  18. 18.

    Le Templier G, Rodger MA (2008) Heparin-induced osteoporosis and pregnancy. Curr Opin Pulm Med 14(5):403–407

  19. 19.

    Folwarczna J, Janiec W, Gawor M, Pytlik M, Kaczmarczyk-Sedlak I et al (2004) Effects of enoxaparin on histomorphometric parameters of bones in rats. Pol J Pharmacol 56(4):451–457

  20. 20.

    Goëb V, Strotz V, Verdet M, Le Loët X, Vittecoq O (2008) Post-partum sacral fracture associated with heparin treatment. Clin Rheumatol 27(Suppl 2):S51–S53

  21. 21.

    Lampropoulou-Adamidou K, Trovas G, Stathopoulos IP, Papaioannou NA (2012) Case report: teriparatide treatment in a case of severe pregnancy—and lactation—associated osteoporosis. Hormones (Athens) 11(4):495–500

Download references

Conflicts of interest

None.

Author information

Correspondence to D. Ozdemir.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Ozdemir, D., Tam, A.A., Dirikoc, A. et al. Postpartum osteoporosis and vertebral fractures in two patients treated with enoxaparin during pregnancy. Osteoporos Int 26, 415–418 (2015). https://doi.org/10.1007/s00198-014-2852-9

Download citation

Keywords

  • Bone mineral density
  • Enoxaparin
  • Fracture
  • Postpartum osteoporosis